We are developing
blood cells for
research of COVID-19!
We are developing a human white blood cells based on Mylc cell optimized for the evaluation of the efficacy and safety of vaccines and drugs for COVID-19, which is shaking the world!
High precision and uniform blood cells produced using regenerative medicine technologies drastically accelerate the evaluation of the efficacy of drugs for COVID-19.
(Please contact us for details.)
We are providing high precision immature blood cells developed for various types of evaluation of drugs and
functional materials for cosmetics and foods,
and offer a contract evaluation service using the blood cells.